Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 315

Results For "MS"

5598 News Found

Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr
News | November 13, 2023

Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr

Sales in the US region grew well, partially offset by the decline in the LATAM and European regions


Marksans Pharma posts Q2 FY24 consolidated PAT at Rs. 82.7 Cr
News | November 13, 2023

Marksans Pharma posts Q2 FY24 consolidated PAT at Rs. 82.7 Cr

US business grew by +12.8% YoY


Sun Pharma joins hands with WOTR to create water harvesting capacity in Maharashtra
News | November 13, 2023

Sun Pharma joins hands with WOTR to create water harvesting capacity in Maharashtra

This collaboration underscores WOTR's unwavering commitment to strengthening rural communities against the unpredictable variations of climate change


Intermountain Health files complain against Dr. Reddy’s and others
News | November 10, 2023

Intermountain Health files complain against Dr. Reddy’s and others

Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation


Bayer posts Q3 2023 Group sales Euro 10.34 billion
News | November 09, 2023

Bayer posts Q3 2023 Group sales Euro 10.34 billion

We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”


Biocon Biologics announces divestment of two non-core branded formulations
News | November 09, 2023

Biocon Biologics announces divestment of two non-core branded formulations

Total transaction value of the divestment is Rs. 3,660 million


Evonik launches GMP-quality plant-based squalene
News | November 08, 2023

Evonik launches GMP-quality plant-based squalene

PhytoSquene now available for clinical and commercial use


Indian pharmaceutical companies have become reliable and affordable suppliers of high-quality drugs: MoS Bhagwant Khuba
Policy | November 08, 2023

Indian pharmaceutical companies have become reliable and affordable suppliers of high-quality drugs: MoS Bhagwant Khuba

Lack of technology transfer stands out as a formidable barrier


Zydus, Guardant Health to promote Guardant360 genomic tests for cancers in India and Nepal
Healthcare | November 04, 2023

Zydus, Guardant Health to promote Guardant360 genomic tests for cancers in India and Nepal

The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region


The Prostate Cancer Foundation and Bayer announce Bayer – PCF Darolutamide Challenge Awards
News | November 03, 2023

The Prostate Cancer Foundation and Bayer announce Bayer – PCF Darolutamide Challenge Awards

In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer